Iron status and clinical outcome in patients with coronary artery disease after coronary stenting

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 15, Issue 6, 2005, Pages 418-425

  Ndrepepa, Gjin ^a   Braun, Siegmund ^a   Dibra, Alban ^a   Mehilli, Julinda ^a   Vogt, Wolfgang ^a   Schömig, Albert ^a   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Coronary artery disease; Iron; Restenosis; Stents

Indexed keywords

FERRITIN; IRON; TRANSFERRIN RECEPTOR;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; COHORT ANALYSIS; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NUTRITIONAL STATUS; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; RISK FACTOR; STENT; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DISEASE-FREE SURVIVAL; FEMALE; FERRITINS; HUMANS; IRON; MALE; MIDDLE AGED; NUTRITIONAL STATUS; POSTOPERATIVE COMPLICATIONS; RECEPTORS, TRANSFERRIN; RECURRENCE; RISK FACTORS; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33646203495     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.02.005     Document Type: Article

References (29)

1. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-4.
2. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998;97:1461-6.
3. Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999;99:852-4.
4. de Valk B, Marx JJM. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999;159:1542-8.
5. Sempos CT, Looker AC, Gillum RF, Mcgee DL, Vuong CV, Johnson CL. Serum ferritin and death from all causes and cardiovascular disease. The NHANES II Mortality Study. Ann Epidemiol 2000;10:441-8.
6. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001;103:52-7.
7. Erbel R, Haude M, Hopp HW, Franzen D, Rupprecht HJ, Heublein B, et al. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. N Engl J Med 1998;339:1672-8.
8. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
9. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-9.
10. World Health Organization. Diabetes mellitus. WHO Tech Rep Ser 1985;727:1-104.
11. Kolbe-Busch S, Lotz J, Hafner G, Blanckaert NJ, Claeys G, Togni G, et al. Multicenter evaluation of a fully mechanized soluble transferrin receptor assay on the Hitachi and Cobas Integra analyzers. The determination of reference ranges. Clin Chem Lab Med 2002;40:529-36.
12. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82:1193-202.
13. Pahl PM, Yan XD, Hodges YK, Rosenthal EA, Horwitz MA, Horwitz LD. An exochelin of Mycobacterium tuberculosis reversibly arrests growth of human vascular smooth muscle cells in vitro. J Biol Chem 2000;275:17821-6.
14. Rosenthal EA, Bohlmeyer TJ, Monnet E, MacPhail C, Robertson AD, Horwitz MA, et al. An iron-binding exochelin prevents restenosis due to coronary artery balloon injury in a porcine model. Circulation 2001;104:2222-7.
15. Bräsen JH, Kivela A, Roser K, Rissanen TT, Niemi M, Luft FC, et al. Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries. Arterioscler Thromb Vasc Biol 2001;21:1720-6.
16. Day SM, Duquaine D, Mundada LV, Menon RG, Khan BV, Rajagopalan S, et al. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 2003;107:2601-6.
17. Liu MW, Roubin GS, King 3rd SB. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 1989;79:1374-87.
18. Gaenzer H, Marschang P, Sturm W, Neumayr G, Vogel W, Patsch J, et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 2002;40:2189-94.
19. Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney Jr JF, et al. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 2001;103:2799-804.
20. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Lopez-Bermejo A, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care 2002;25:2249-55.
21. Roest M, van der Schouw YT, de Valk B, Marx JJ, Tempelman MJ, de Groot PG, et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999;100:1268-73.
22. Braun S, Ndrepepa G, von Beckerath N, Vogt W, Schömig A, Kastrati A. Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations. Atherosclerosis 2004;174:105-10.
23. Baynes RD. Assessment of iron status. Clin Biochem 1996;29:209-15.
24. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101:3359-64.
25. Sullivan JL. Iron and the genetics of cardiovascular disease. Circulation 1999;100:1260-3.
26. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 1992;286:901-5.
27. Thong PS, Selley M, Watt F. Elemental changes in atherosclerotic lesions using nuclear microscopy. Cell Mol Biol 1996;42:103-10.
28. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996;1275:161-203.
29. Rogers JT. Ferritin translation by interleukin-1 and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 1996;87:2525-37.